Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ACP SR Sprinkles
- Development stage
- Unknown
- Lead developer
- Confluence Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ACP SR Sprinkles is an investigational, sustained-release oral formulation of acamprosate developed by Confluence Pharmaceuticals. It is specifically designed for pediatric populations with Fragile X Syndrome and Autism Spectrum Disorders, utilizing a "sprinkle" format that can be mixed with food to accommodate patients with sensory or mechanical swallowing difficulties. Acamprosate is a small molecule that modulates the central nervous system by acting as an NMDA receptor antagonist and a GABA receptor modulator, aiming to correct the imbalance between excitatory and inhibitory signaling characteristic of these neurodevelopmental disorders. The formulation has received Orphan Drug Designation from both the FDA and EMA for the treatment of Fragile X Syndrome.
- Other names
- Acamprosate SR sprinklesACP SR
02
Targets
GABRR (GABA-A receptor subunit rho)NMDAR (Glutamate receptor ionotropic, NMDA)
Beyond the preview
Go deeper on ACP SR Sprinkles.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACP SR Sprinkles.